879487-87-3
Chemical Structure
R-268712
- CAS No.: 879487-87-3
- Formula:C20H18FN5O
- Molecular Weight:363.39
IUPAC Name: 2-(4-(2-fluoro-5-(3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-ol
InChIKey: JQGOCCALXFSRHZ-UHFFFAOYSA-N
SMILES: FC1=C(C2=CN(CCO)N=C2)C=C(C3=CNN=C3C4=CC=CC(C)=N4)C=C1
Biological Activity: R-268712 is an orally active and selective ALK-5 inhibitor, with an IC50 of 2.5 nM. R-268712 inhibits the phosphorylation of Smad3 in a dose-dependent manner with an IC50 of 10.4 nM. R-268712 suppresses glomerulonephritis as well as glomerulosclerosis by inhibiting TGF-β signaling, which can be used in studies of renal fibrosis and cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
R-268712 | 99.92% | R-268712 is an orally active and selective ALK-5 inhibitor, with an IC50 of 2.5 nM. R-268712 inhibits the phosphorylation of Smad3 in a dose-dependent manner with an IC50 of 10.4 nM. R-268712 suppresses glomerulonephritis as well as glomerulosclerosis by inhibiting TGF-β signaling, which can be used in studies of renal fibrosis and cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.63
HY-118810BIO-013077-01 -
Similarity Score 0.58
HY-78349A 77-01 -
Similarity Score 0.57
HY-W707119RepSox hydrochloride -
Similarity Score 0.57
HY-13012RepSox -
Similarity Score 0.55
HY-10327GW-6604 -
Similarity Score 0.52
HY-149403J-1048 -
Similarity Score 0.51
HY-144043ALK5-IN-8 -
Similarity Score 0.51
HY-182547LY580276 -
Similarity Score 0.51
HY-10326RGW788388 (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. Terashima H, et al. Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors. Pulm Pharmacol Ther. 2019 Feb;54:31-38. [Content Brief]
- [2]. Terashima H, et al. R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. Eur J Pharmacol. 2014 Jul 5;734:60-6. [Content Brief]
